Literature DB >> 17097829

Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer.

Ina Kyas1, Holger Hof, Jürgen Debus, Wolfgang Schlegel, Christian P Karger.   

Abstract

PURPOSE: To estimate the risk of radiation-induced changes in the lung before single-dose treatment (stereotactic body radiation therapy [SBRT]) of lung cancer, the quantitative dose-response and volume-response relations must be known. METHODS AND MATERIALS: A total of 64 patients treated for non-small-cell lung cancer with single doses of 20-30 Gy were classified according to the occurrence or nonoccurrence of perifocal changes in the lung detected by CT. Patients without toxic events in the lung were required to have >or=6 months of follow-up. The mean dose (D(mean)) in the ipsilateral lung and the volume receiving >7 or 10 Gy (V7 and V10, respectively) were used to calculate the dose-response and volume-response curves. The predictive value of additional variables was also investigated.
RESULTS: Of the 64 patients, 83% exhibited the selected endpoint. The tolerance values at a 50% probability of toxic events were 1.2 +/- 0.7 Gy for the D(mean) and 5.8 +/- 3.0% and 3.1 +/- 2.0% for V7 and V10, respectively. A nonsignificant shift to higher doses was seen for the dose-response curve for the upper compared with the lower part of the lung.
CONCLUSION: The D(mean), V7, and V10 can be used to predict the risk of lung toxicity after SBRT treatment of non-small-cell lung cancer. Because of the lack of patients with low prescribed doses, however, the related uncertainty of this prediction is still relatively large. The D(mean), V7, and V10 are equally well suited. The additional investigated variables did not provide significant advantages. The lower part of the lung appears to be more radiosensitive than the upper.

Entities:  

Mesh:

Year:  2006        PMID: 17097829     DOI: 10.1016/j.ijrobp.2006.08.066

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent.

Authors:  T Eldh; F Heinzelmann; A Velalakan; W Budach; C Belka; V Jendrossek
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

2.  Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis.

Authors:  Shinsaku Yamaguchi; Takayuki Ohguri; Yuichi Matsuki; Katsuya Yahara; Hodaka Oki; Hajime Imada; Hiroyuki Narisada; Yukunori Korogi
Journal:  Int J Clin Oncol       Date:  2014-03-11       Impact factor: 3.402

3.  Dosimetric evaluation of abdominal compression as a method to reduce the incidence of radiation-induced pneumonitis in lung SBRT treatment.

Authors:  Vikren Sarkar; Long Huang; Yu-Huei Jessica Huang; Martin W Szegedi; Prema Rassiah-Szegedi; Hui Zhao; Ying J Hitchcock; Kristine E Kokeny; Brian Wang; Bill J Salter
Journal:  J Radiosurg SBRT       Date:  2016

4.  Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.

Authors:  A Takeda; T Ohashi; E Kunieda; N Sanuki; T Enomoto; T Takeda; Y Oku; N Shigematsu
Journal:  Br J Radiol       Date:  2012-01-17       Impact factor: 3.039

5.  Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.

Authors:  M Ishijima; H Nakayama; T Itonaga; Y Tajima; S Shiraishi; M Okubo; R Mikami; K Tokuuye
Journal:  Br J Radiol       Date:  2014-12-09       Impact factor: 3.039

6.  Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy.

Authors:  Sibo Tian; Jeffrey M Switchenko; Richard J Cassidy; Chase E Escott; Richard Castillo; Pretesh R Patel; Walter J Curran; Kristin A Higgins
Journal:  Transl Lung Cancer Res       Date:  2019-02

Review 7.  Complications from Stereotactic Body Radiotherapy for Lung Cancer.

Authors:  Kylie H Kang; Christian C Okoye; Ravi B Patel; Shankar Siva; Tithi Biswas; Rodney J Ellis; Min Yao; Mitchell Machtay; Simon S Lo
Journal:  Cancers (Basel)       Date:  2015-06-15       Impact factor: 6.639

8.  Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations.

Authors:  Tania De La Fuente Herman; Maria T Vlachaki; Terence S Herman; Kerry Hibbitts; Julie A Stoner; Salahuddin Ahmad
Journal:  J Appl Clin Med Phys       Date:  2010-01-29       Impact factor: 2.102

9.  Volume Modulated Arc Therapy (VMAT) for pulmonary Stereotactic Body Radiotherapy (SBRT) in patients with lesions in close approximation to the chest wall.

Authors:  Linda Ding; Yuan-Chyuan Lo; Sidney Kadish; David Goff; Richard S Pieters; Geoffrey Graeber; Karl Uy; Syed Quadri; Richard Moser; Kevin Martin; John Day; Thomas J Fitzgerald
Journal:  Front Oncol       Date:  2013-02-22       Impact factor: 6.244

Review 10.  Normal tissue toxicity after small field hypofractionated stereotactic body radiation.

Authors:  Michael T Milano; Louis S Constine; Paul Okunieff
Journal:  Radiat Oncol       Date:  2008-10-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.